SVP and CFO Thomas R Staab II sold $85K of BioCryst Pharmaceuticals, Inc.

Sold$85,090

$7.84Price

10,856Shares

−7%Stake

What BCRX did after the filing

Prices for BCRX after this filing aren't in yet.

Traded Fri, Nov 2. Filed Tue, Nov 6, 4:04 PM ET, after the close. Not investment advice.